Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.66% |
| 2 | Financials | 14.07% |
| 3 | Healthcare | 13.55% |
| 4 | Consumer Discretionary | 11.86% |
| 5 | Communication Services | 10.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Latham Group
SWIM
$881M
| $7.2M | ﹤0.01% |
438,798
+2,865
| +0.7% | +$66.8K |
|
|
CSTR
2702
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $7.18M | ﹤0.01% |
338,100
+6,125
| +2% | +$128K |
|
2703
National Presto Industries
NPK
$998M
| $7.17M | ﹤0.01% |
87,338
-1,425
| -2% | -$128K |
|
|
VEI
2704
DELISTED
Vine Energy Inc.
VEI
| $7.14M | ﹤0.01% |
433,804
+45,403
| +12% | +$681K |
|
2705
Ascendis Pharma A/S
ASND
$16B
| $7.14M | ﹤0.01% |
44,796
+519
| +1% | +$71K |
|
2706
Liberty Latin America Class A
LILA
$1.68B
| $7.13M | ﹤0.01% |
802,402
+59,591
| +8% | +$550K |
|
2707
OneWater Marine
ONEW
$199M
| $7.12M | ﹤0.01% |
177,073
+3,265
| +2% | +$137K |
|
2708
Willdan Group
WLDN
$1.31B
| $7.11M | ﹤0.01% |
199,838
+8,876
| +5% | +$334K |
|
|
ORGN
2709
DELISTED
Origin Materials
ORGN
| $7.11M | ﹤0.01% |
34,798
+32,446
| +1,380% | +$6.68M |
|
|
ME
2710
DELISTED
23andMe Holding Co
ME
| $7.09M | ﹤0.01% |
39,158
+35,331
| +923% | +$6.28M |
|
|
API
2711
Agora
API
$383M
| $7.05M | ﹤0.01% |
244,732
+22,352
| +10% | +$697K |
|
2712
ACV Auctions
ACVA
$1.36B
| $7.05M | ﹤0.01% |
393,868
+216,060
| +122% | +$4.59M |
|
2713
Farmers National Banc Corp
FMNB
$975M
| $7.01M | ﹤0.01% |
446,255
-3,348
| -0.7% | -$51.5K |
|
|
APPH
2714
DELISTED
AppHarvest, Inc. Common Stock
APPH
| $7M | ﹤0.01% |
1,074,506
+58,295
| +6% | +$579K |
|
2715
GSK
GSK
$97.9B
| $7M | ﹤0.01% |
146,513
+5,754
| +4% | +$289K |
|
2716
908 Devices
MASS
$425M
| $6.99M | ﹤0.01% |
214,848
+86,641
| +68% | +$2.94M |
|
2717
CleanSpark
CLSK
$2.99B
| $6.96M | ﹤0.01% |
600,900
+61,601
| +11% | +$829K |
|
2718
SAP
SAP
$242B
| $6.91M | ﹤0.01% |
51,174
+15,046
| +42% | +$2.18M |
|
|
XONE
2719
DELISTED
The ExOne Company
XONE
| $6.9M | ﹤0.01% |
295,251
+19,344
| +7% | +$406K |
|
2720
Atossa Therapeutics
ATOS
$24.2M
| $6.88M | ﹤0.01% |
140,611
+9,361
| +7% | +$545K |
|
|
PAE
2721
DELISTED
PAE Incorporated Class A Common Stock
PAE
| $6.88M | ﹤0.01% |
1,149,733
+24,376
| +2% | +$187K |
|
2722
Cytek Biosciences
CTKB
$632M
| $6.87M | ﹤0.01% |
+321,108
| New | +$7.55M |
|
2723
Apyx Medical
APYX
$130M
| $6.86M | ﹤0.01% |
495,470
+5,388
| +1% | +$56.7K |
|
2724
FRP Holdings
FRPH
$428M
| $6.86M | ﹤0.01% |
245,288
-692
| -0.3% | -$19.9K |
|
2725
American Vanguard Corp
AVD
$63.4M
| $6.86M | ﹤0.01% |
455,498
-2,340
| -0.5% | -$37K |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.